InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Lilly Jason Warren, Chairman & CEO. Director active across 1 companies, notably NEOGEN CORP. Aggregated, 6 disclosures have been logged. Total volume traded: €56k. The latest transaction was filed on 23 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€17,600636 shares@ €27.67265.4% of flow
Common Stock
SEC:0000711377-21-000035·
€17,600636 shares@ €27.67260.0014% mcap2.7% of flow
Common Stock
SEC:0000711377-21-000035:0·
€279,63315,998 shares@ €17.479286.0% of flow
Common Stock
SEC:0000711377-21-000021·
€279,63315,998 shares@ €17.47920.022% mcap43.0% of flow
Common Stock
SEC:0000711377-21-000021:0·
€28,070350 shares@ €80.19888.6% of flow
Common Stock
SEC:0000711377-21-000018·
€28,070350 shares@ €80.19880.0022% mcap4.3% of flow
Common Stock
SEC:0000711377-21-000018:0·
6 of 6 declarations
About Lilly Jason Warren
Jason Warren Lilly is the Chairman & CEO at NEOGEN CORP. He oversees the company's operations and is responsible for international growth strategy. His role involves leading initiatives that strengthen NEOGEN's position in the global market. Through his expertise, he contributes to innovation and expansion of the company's activities.
